Literature DB >> 2321642

The transtubular potassium concentration in patients with hypokalemia and hyperkalemia.

J H Ethier1, K S Kamel, P O Magner, J Lemann, M L Halperin.   

Abstract

It is advantageous to make an independent assessment of the potassium (K) secretory process and the luminal flow rate in the renal cortex to evaluate K handling by the kidney during hypokalemia or hyperkalemia. The transtubular potassium concentration gradient (TTKG) is a semiquantitative index of the activity of the K secretory process. The purpose of this study was to define expected values for the TTKG in normal subjects with hypokalemia or following an acute K load. During hypokalemia of non-renal origin, the TTKG was 0.9 +/- 0.2; in contrast, the TTKG was significantly higher during the hypokalemia of hyperaldosteronism, 6.7 +/- 1.3. The TTKG was 11.8 +/- 3.6, 2 hours after normokalemic subjects received 0.2 mg 9 alpha-fludrocortisone (9 alpha-F). To obtain expected values during hyperkalemia, normal subjects ingested 50 mmol potassium chloride; 2 hours later, the TTKG was 13.1 +/- 3.8. Therefore, the expected value for the TTKG must be interpreted relative to the concentration of K in the plasma. Circumstances were also defined where the TTKG is low despite hyperaldosteronism, namely, during a water diuresis and pre-existing hypokalemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2321642     DOI: 10.1016/s0272-6386(12)80076-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  22 in total

1.  Acute cardiac arrest secondary to severe hyperkalemia due to autoimmune polyendocrine syndrome type II.

Authors:  Michael Huntgeburth; Matthias Laudes; Volker Burst; Stefan Krämer; Hannes Reuter; Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2010-12-14       Impact factor: 5.460

2.  Thyrotoxic periodic paralysis.

Authors:  Lien Lam; Rajasree J Nair; Leslie Tingle
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-04

3.  Periodic hypokalemia associated with cyclic Cushing's syndrome.

Authors:  Hiroaki Kikuchi; Takanobu Yoshimoto; Hiroyuki Tanaka; Kazutaka Tsujimoto; Chisato Yamamura; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Makoto Aoyagi; Yoshihiro Ogawa; Teiichi Tamura
Journal:  CEN Case Rep       Date:  2013-08-09

4.  Urinary aquaporin-2 excretion during early human development.

Authors:  Marina Zelenina; Yanhong Li; Isabelle Glorieux; Catherine Arnaud; Christelle Cristini; Stéphane Decramer; Anita Aperia; Charlotte Casper
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

5.  Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.

Authors:  Anne Blanchard; Michael Frank; Grégoire Wuerzner; Severine Peyrard; Lise Bankir; Xavier Jeunemaitre; Michel Azizi
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 8.237

Review 6.  Hypokalaemia and hyperkalaemia.

Authors:  A Rastegar; M Soleimani; A Rastergar
Journal:  Postgrad Med J       Date:  2001-12       Impact factor: 2.401

7.  Requirements for a high rate of potassium excretion in rats consuming a low electrolyte diet.

Authors:  Surinder Cheema-Dhadli; Shih-Hua Lin; Chee Keong-Chong; Kamel S Kamel; Mitchell L Halperin
Journal:  J Physiol       Date:  2006-02-02       Impact factor: 5.182

8.  Potassium conservation is impaired in mice with reduced renal expression of Kir4.1.

Authors:  Sundeep Malik; Emily Lambert; Junhui Zhang; Tong Wang; Heather L Clark; Michael Cypress; Bruce I Goldman; George A Porter; Salvador Pena; Wilson Nino; Daniel A Gray
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-15

Review 9.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

10.  Renal tubular sodium and water metabolism in brain tumour patients submitted to craniotomy.

Authors:  P Ponce; J Travassos; J Cruz; P Moreira; E M Gomes; J L Antunes
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.